DFNS.net CBRN News Blog


Ricin Vaccine Performs Well in Tulane Study

A recent study at the Tulane National Primate Research Center showed for the first time that an experimental vaccine could completely protect nonhuman primates exposed to deadly ricin toxin, a potential bioterrorism agent. Chad...


New Date: Radiological Detection System Industry Day

A pre-solicitation conference for industry will be held Dec. 4, 2014 at Aberdeen Proving Ground, Md., for the U.S. Department of Defense (DoD) Radiological Detection System (RDS) contracting effort. The event was originally scheduled...


Second Ebola Vaccine Trial in Switzerland

Swissmedic, the Swiss regulatory authority for therapeutic products, has approved a second Swiss trial of an experimental Ebola vaccine. The trial will be led by the University Hospitals of Geneva (HUG). Pending positive safety...


EPA Reaffirms Improved Biosafety for Select Agents

As a result of a series of recent laboratory safety and security incidents that were reported at U.S. government facilities in the Summer of 2014, the White House directed federal departments and agencies to...


Ebola epidemic affects security in West Africa

Key Points West African economies will be severely affected by the largest Ebola outbreak in history as internal trade and international business travel stall considerably. Containment of the current outbreak will require the rapid...


DSCA releases South Korean PAC-3 notification

Key Points The DSCA has released a notification on a possible USD1.405 billion sale of PAC-3 missiles and interceptors to South Korea The notification is the latest in a series of attempts by Washington...


Pandora Report 11.9.14

We’ve got some timely stories this week: just in time for Veteran’s Day, we look at military exposure to chemical agents in Iraq, and at the beginning of flu season we look at the...


DARPA Biotechnology EZ BAA Cuts the Red Tape

The Defense Advanced Research Projects Agency (DARPA) has simplified its Broad Agency Announcement (BAA) proposal process to better attract and fund new ideas in biotechnology. This new Biotechnology EZ BAA, overseen by DARPA’s Biological...


Biodefense Policy Seminar Wrap Up: Part 1

All Biodefense Policy Seminar events for Fall 2014 have concluded. Please enjoy a summary of the October 2014 event and join us for our Spring 2015 series. On Wednesday, October 22, Dr. W. Seth...


Pentagon Counter-IED Group Heads to Iraq as Attacks Surge

DEFENSE ONE – The Pentagon’s Joint IED Defeat Organization (JIEDDO) is preparing to deploy members to Iraq where 145 roadside bomb attacks carried out by Islamic State militants killed more than 804 people and...


NCT CBRNe USA – Call for Papers

IB Consultancy, in partnership with the National Consortium for the Study of Terrorism and Responses to Terrorism (START) is calling for papers to be presented at the Non-Conventional Threat (NCT) CBRNe USA 2015 conference....


European nations begin maritime counter-mine research

Five European Defence Agency (EDA) countries, plus Norway, have begun research on a new generation of maritime counter-mine measures. The three-year project aims to define capabilities that can either be back-fitted onto existing vessels...


Dutch open European C-IED facility

On 4 November the first counter-improvised explosive devices (C-IED) Joint Deployable Exploitation and Analysis Laboratory (JDEAL) was declared operational at the ‘Kamp Soesterberg’ barracks in the Netherlands. The facility was initiated and funded by...


Russia exercises its strategic nuclear ‘triad’

Since 28 October Moscow has tested and exercised all three components of its nuclear arsenal, including the firing of submarine-launched and land-based intercontinental ballistic missiles (SLBMs and ICBMs) as well as extensive long-range strategic...


Aegis BMD hits three targets in intercept trial

The US Aegis Ballistic Missile Defense (BMD) system notched three near-simultaneous target intercepts during a 6 November flight test. USS John Paul Jones (DDG 53), configured with the Aegis Baseline (BL) 9.C1 (BMD 5.0...

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.